The role of epigenetics and long noncoding RNA MIAT in neuroendocrine prostate cancer.
about
Identification of long non-coding RNA 00312 and 00673 in human NSCLC tissues.Long non-coding RNA MIAT knockdown promotes osteogenic differentiation of human adipose-derived stem cells.lncRNA MIAT functions as a competing endogenous RNA to upregulate DAPK2 by sponging miR-22-3p in diabetic cardiomyopathy.Decoding critical long non-coding RNA in ovarian cancer epithelial-to-mesenchymal transition.Long noncoding RNA MIAT promotes non-small cell lung cancer proliferation and metastasis through MMP9 activation.Long non-coding RNA MIAT promotes breast cancer progression and functions as ceRNA to regulate DUSP7 expression by sponging miR-155-5p.lncRNAs PVT1 and HAR1A are prognosis biomarkers and indicate therapy outcome for diffuse glioma patients.Reduction of two histone marks, H3k9me3 and H3k27me3 by epidrug induces neuroendocrine differentiation in prostate cancer.Long noncoding RNA BLACAT2 promotes bladder cancer-associated lymphangiogenesis and lymphatic metastasis.Silencing of Long Non-coding RNA MIAT Sensitizes Lung Cancer Cells to Gefitinib by Epigenetically Regulating miR-34a.Interplay between long non-coding RNAs and epigenetic machinery: emerging targets in cancer?Long non-coding RNA MIAT promotes gastric cancer growth and metastasis through regulation of miR-141/DDX5 pathway.Long non-coding RNA MIAT in development and disease: a new player in an old game.Long non-coding RNA CCAT1 as a diagnostic and prognostic molecular marker in various cancers: a meta-analysis.Long non-coding RNA MIAT promotes growth and metastasis of colorectal cancer cells through regulation of miR-132/Derlin-1 pathway.
P2860
Q38604534-831A3720-112E-435C-B26C-DF0426F52354Q40416741-BDE43B03-9584-41B0-9F7B-D0693D642961Q41335448-F865A05F-F630-47BD-BEC8-59911663ECCFQ47095768-51422E45-352E-4163-8567-0AA1FED13556Q47106319-B828808A-E039-4A6D-876A-CEDD5E1B0F3BQ47123227-95F76A92-207E-4059-A2D8-569892CA81A8Q47262117-5DC79853-AD0B-4D48-BB29-A95C632E1783Q48125169-64C5EA69-47FC-4BFA-AC47-DC7F9FEB55B0Q49884430-F84ECC3F-23A7-4410-8948-0D2AB77858F4Q50318108-2147A6DF-A5E9-472A-A5A8-141E7251A599Q52312154-F2B770EE-4FF9-4752-B53B-6414C6516494Q52655654-1F9A55B3-92E1-47D1-A242-C8B859B536D9Q52657624-F46E814A-A894-4FDE-8500-7E6EF40522A8Q55004353-B281FBA2-11A6-4CFF-B25E-7B1D1725C802Q55361066-3CB2A661-997F-4CB0-9082-4E5434E3A250
P2860
The role of epigenetics and long noncoding RNA MIAT in neuroendocrine prostate cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
The role of epigenetics and long noncoding RNA MIAT in neuroendocrine prostate cancer.
@en
The role of epigenetics and long noncoding RNA MIAT in neuroendocrine prostate cancer.
@nl
type
label
The role of epigenetics and long noncoding RNA MIAT in neuroendocrine prostate cancer.
@en
The role of epigenetics and long noncoding RNA MIAT in neuroendocrine prostate cancer.
@nl
prefLabel
The role of epigenetics and long noncoding RNA MIAT in neuroendocrine prostate cancer.
@en
The role of epigenetics and long noncoding RNA MIAT in neuroendocrine prostate cancer.
@nl
P2093
P2860
P356
P1433
P1476
The role of epigenetics and long noncoding RNA MIAT in neuroendocrine prostate cancer
@en
P2093
Abhijit Parolia
Colin Collins
Erik Venalainen
Hongwei Cheng
Larissa Pikor
Nur Ridzwan Nur Saidy
P2860
P304
P356
10.2217/EPI.16.6
P577
2016-04-20T00:00:00Z